Covered recipient · General Payments record
LINDA LEBOURGEOIS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,530.43
- Reported across 134 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.20 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $217.27 | 26 |
| Teva Pharmaceuticals USA, Inc. | $63.16 | 3 |
| Lundbeck LLC | $61.84 | 3 |
| ARGENX US, INC. | $42.56 | 2 |
| MDD US Operations, LLC | $21.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.00 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148798 | CMS |
| ABBVIE INC. | $6.88 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148800 | CMS |
| ABBVIE INC. | $8.01 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148802 | CMS |
| ABBVIE INC. | $14.33 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148804 | CMS |
| ABBVIE INC. | $8.70 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148806 | CMS |
| ABBVIE INC. | $10.38 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148808 | CMS |
| ABBVIE INC. | $6.94 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148810 | CMS |
| ABBVIE INC. | $2.75 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148812 | CMS |
| ABBVIE INC. | $7.54 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148814 | CMS |
| ABBVIE INC. | $4.67 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148816 | CMS |
| ABBVIE INC. | $6.89 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148818 | CMS |
| ABBVIE INC. | $9.31 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148820 | CMS |
| ABBVIE INC. | $10.19 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148822 | CMS |
| ABBVIE INC. | $6.51 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148824 | CMS |
| ABBVIE INC. | $10.40 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148826 | CMS |
| ABBVIE INC. | $19.72 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148828 | CMS |
| ABBVIE INC. | $5.91 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148830 | CMS |
| ABBVIE INC. | $11.57 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148832 | CMS |
| ABBVIE INC. | $6.03 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148834 | CMS |
| ABBVIE INC. | $7.97 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148836 | CMS |
| ABBVIE INC. | $5.04 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148838 | CMS |
| ABBVIE INC. | $12.06 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148840 | CMS |
| ABBVIE INC. | $3.99 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148842 | CMS |
| ABBVIE INC. | $3.57 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148844 | CMS |
| ABBVIE INC. | $13.99 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148846 | CMS |
| ABBVIE INC. | $4.92 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104148848 | CMS |
| ARGENX US, INC. | $25.15 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112183 | CMS |
| ARGENX US, INC. | $17.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142122963 | CMS |
| Lundbeck LLC | $18.31 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145938402 | CMS |
| Lundbeck LLC | $28.67 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145938404 | CMS |
| Lundbeck LLC | $14.86 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145938406 | CMS |
| MDD US Operations, LLC | $21.37 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147749754 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151477760 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.45 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151477798 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.55 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151477836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.